B4GALT7

Across TCGA pan-cancer cohorts, B4GALT7 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated B4GALT7 data layer compared with 5 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher B4GALT7 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated B4GALT7 expression acts as an unfavorable survival marker, although some lineages such as READ and DLBC show a favorable association.

READ, KIRC, and UCS are the cancer types where B4GALT7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Median	All	0.939	0.556	<.001	47	view →
KIRC	OS	Tertile	All	0.737	0.848	.001	45	view →
UCS	OS	Median	III,IV	0.437	0.723	.019	42	view →
LIHC	DFS	Tertile	All	0.436	0.621	<.001	40	view →
LUSC	DFS	Tertile	III,IV	0.207	0.578	<.001	37	view →
LGG	OS	Quartile	All	0.735	0.897	<.001	34	view →
COAD	OS	Median	All	0.805	0.926	<.001	25	view →
DLBC	DFS	Tertile	All	1.000	0.366	.008	24	view →
SCLC	DFS	Tertile	All	1.000	0.545	.002	22	view →
HNSC	OS	Median	All	0.637	0.788	.008	21	view →
ACC	DFS	Quartile	III,IV	0.482	0.087	.019	20	view →
PAAD	DFS	Tertile	All	0.459	0.147	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

B4GALT7–READ (DFS)

Open the READ breakdown →